Apogee Therapeutics Inc

APGE

Company Profile

  • Business description

    Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

  • Contact

    221 Crescent Street
    Building 17, Suite 102b
    WalthamMA02453
    USA

    T: +1 650 394-5230

    https://www.apogeetherapeutics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    261

Stocks News & Analysis

stocks

Undervalued REIT delivers strong earnings growth

ASX REIT remains undervalued despite result.
stocks

Disney earnings: Experiences and streaming again drive excellent results

We believe Disney’s irreplaceable characters will continue to drive a healthy experiences business, which we estimate is worth nearly as much as the market values the whole firm.
stocks

ASX utility share downgraded as electricity prices fall

Falling electricity prices weigh on earnings outlook for utility provider.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,452.0042.100.45%
CAC 408,699.7130.420.35%
DAX 4026,140.1313.830.05%
Dow JONES (US)53,885.10464.02-0.85%
FTSE 10010,867.8920.41-0.19%
HKSE25,530.28385.54-1.49%
NASDAQ26,348.3515.09-0.06%
Nikkei 22565,683.26617.18-0.93%
NZX 50 Index13,958.0639.12-0.28%
S&P 5007,709.9613.59-0.18%
S&P/ASX 2009,271.6041.800.45%
SSE Composite Index3,900.3521.920.57%

Market Movers